GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Ventures Inc (XCNQ:J) » Definitions » EPS (Diluted)

Lotus Ventures (XCNQ:J) EPS (Diluted) : C$-0.02 (TTM As of Aug. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Ventures EPS (Diluted)?

Lotus Ventures's Earnings per Share (Diluted) for the three months ended in Aug. 2023 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was C$-0.02.

Lotus Ventures's EPS (Basic) for the three months ended in Aug. 2023 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2023 was C$-0.02.

Lotus Ventures's EPS without NRI for the three months ended in Aug. 2023 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2023 was C$-0.02.

During the past 3 years, the average EPS without NRIGrowth Rate was -7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Lotus Ventures's highest 3-Year average EPS without NRI Growth Rate was 24.80% per year. The lowest was -20.80% per year. And the median was -14.50% per year.


Lotus Ventures EPS (Diluted) Historical Data

The historical data trend for Lotus Ventures's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Ventures EPS (Diluted) Chart

Lotus Ventures Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.04 0.02 - -0.05

Lotus Ventures Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.01 - - -0.01

Competitive Comparison of Lotus Ventures's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Ventures's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Ventures's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Ventures's PE Ratio distribution charts can be found below:

* The bar in red indicates where Lotus Ventures's PE Ratio falls into.



Lotus Ventures EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Lotus Ventures's Diluted EPS for the fiscal year that ended in Aug. 2022 is calculated as

Diluted EPS (A: Aug. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.793-0)/89.970
=-0.05

Lotus Ventures's Diluted EPS for the quarter that ended in Aug. 2023 is calculated as

Diluted EPS (Q: Aug. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.636-0)/89.970
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Ventures  (XCNQ:J) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lotus Ventures EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Lotus Ventures's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Ventures (XCNQ:J) Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 1010, Vancouver, BC, CAN, V6E 2Y3
Lotus Ventures Inc is a licensed cannabis producer that serves customers in Canada. The company created a purpose-built facility with proprietary standard operating procedures to reliably produce rare and high-quality strains of cannabis for consumers looking for a consistent experience.
Executives
Gary Kenneth Mathiesen Senior Officer